Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Caitlin E. Cox

September 23, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

Advertisement

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

TCTMD’s Top 10 Most Popular Stories for September 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Trimetazidine Safe but Not Protective Long-term After PCI

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Most Stable Angina Patients Not Taking First-line Meds

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content